[ Visit Client Website ]

Before you can access ASH's online program, you must agree to the following:
  • Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
  • The media, companies and institutions issuing press releases, and others are required to abide by the embargo policies governing the Society’s annual meeting. Read ASH’s embargo policy for more information.
-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant

Keyword Index: L

[ 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
Laminin
217
Large Granular Lymphocytic Leukemia
932, 936
L-asparaginase
Late Complications and Outcome
Late Effects
Late Mortality
Lentiviral Transduction
Lentiviral Vector
Lentivirus
Leukemia-Associated Antigen
Leukemia Cell Line
Leukemia Cells
Leukemic Stem Cell
Leukemogenesis
Leukocytes
Leukotriene
LGL
Lineage Commitment
Linkage
Lipid Metabolism
Lipid Rafts
Liver
Liver Biopsy
Liver Disease
Liver Injury
LMO2
LOH
295
Long-Term Follow-Up
Low Molecular Weight Heparin
Lung
880
Lung Cancer
Lymphocyte
Lymphoid Malignancy
Lymphomagenesis
Lymphoma Therapy
Lymphoplasmacytic Lymphoma
Lymphopoiesis
Lymphoproliferative Disorder
Lyn Kinase
Lysosomal Storage Disease
[ 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]